Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-10-04T22:23:59Z
No. of bitstreams: 1
DalilaNascimentoManso_DISSERT.pdf: 1914411 bytes, checksum: 966fc442e252d656c3946bff697a75f5 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-10-13T21:33:08Z (GMT) No. of bitstreams: 1
DalilaNascimentoManso_DISSERT.pdf: 1914411 bytes, checksum: 966fc442e252d656c3946bff697a75f5 (MD5) / Made available in DSpace on 2017-10-13T21:33:08Z (GMT). No. of bitstreams: 1
DalilaNascimentoManso_DISSERT.pdf: 1914411 bytes, checksum: 966fc442e252d656c3946bff697a75f5 (MD5)
Previous issue date: 2017-04-19 / A mais recente pandemia do v?rus influenza ocorreu no ano de 2009, causada pela cepa do influenza A (H1N1), e popularmente conhecida como gripe A ou gripe su?na, gerou preocupa??o aos ?rg?os mundiais de sa?de. Com um quadro sintom?tico que inclui febre, tosse, inflama??o na garganta na maioria dos casos, alguns pacientes, principalmente imunossuprimidos que podem apresentar complica??es que evoluem ao ?bito. A transmiss?o do v?rus ocorre atrav?s do contato entre pessoa a pessoa e seu mecanismo de infec??o se d? a partir das duas glicoprote?nas de superf?cie, a hemaglutinina e a neuraminidase. A hemaglutinina atua se ligando aos receptores do ?cido si?lico favorecendo a entrada do v?rus nas c?lulas-alvo e a neuraminidase cliva as c?lulas do receptor de res?duos do ?cido si?lico, onde as novas part?culas virais est?o se ligando. Atrav?s dessa quebra haver? libera??o das novas part?culas virais, que atrav?s da hemaglutinina invadir?o novas c?lulas. Baseado nisso, f?rmacos foram desenvolvidos com intuito de inibir a a??o da neuraminidase, os chamados inibidores da neuraminidase que interferem na libera??o dessas novas part?culas virais evitando a dissemina??o da infec??o no trato respirat?rio. Dentre estes inibidores o oseltamivir ? o f?rmaco de escolha para profilaxia e tratamento da gripe A; por?m, relatos de resist?ncia a esse f?rmaco foram descritos, o que causou preocupa??o nos profissionais da sa?de e governantes. A muta??o mais encontrada ? a HIS275TIR, onde a histidina ? substitu?da por uma tirosina, promovendo uma s?rie de altera??es conformacionais que diminuem a afinidade do f?rmaco pelo v?rus originando a resist?ncia. A partir da obten??o de dados cristalogr?ficos e simula??o computacional, calculamos a energia de intera??o da neuraminidase selvagem e com a presen?a da muta??o HIS275TIR ligadas ao oseltamivir utilizando a Teoria Funcional da Densidade (DFT) e do M?todo de Fracionamento Molecular com Capas Conjugadas (MFCC). Obtivemos 115 res?duos de intera??o para a neuraminidase selvagem (cristal 4B7R) e 109 res?duos de intera??o para o cristal com a neuraminidase mutante (3CL0). Os resultados foram avaliados de acordo com a relev?ncia dos valores energ?ticos para energias repulsivas e energias atrativas. Os c?lculos energ?ticos realizados confirmaram a redu??o da afinidade da cepa contendo a muta??o HIS275TIR e destacaram a import?ncia energ?tica do s?tio ativo da neuraminidase mostrando que os principais res?duos energ?ticos s?o encontrados nele tornando um alvo para obten??o de novos f?rmacos devido a sua conserva??o. As altera??es causadas pela substitui??o do amino?cido histidina por uma tirosina levaram a uma s?rie de mudan?as conformacionais nos amino?cidos vizinhos que provocaram altera??es eletrost?ticas resultando na resist?ncia ao f?rmaco. A partir desse estudo ser? poss?vel conhecer melhor as intera??es moleculares da neuraminidase mutante e posteriormente projetar novos designs de f?rmacos para serem elaborados e se tornarem mais eficientes na intera??o com as cepas mutantes desse v?rus. / The latest influenza pandemic occurred in the year 2009, caused by the strain of influenza A (H1N1), and popularly known as influenza A or swine flu, generated concern to the global health agencies. With a symptomatic picture that includes fever, cough, throat inflammation in most cases, some patients, mainly immunosuppressed, that can to present complications that evolve to death. Transmission of the virus takes place through contact between person to person and its mechanism of infection occurs from the two surface glycoproteins, hemagglutinin and neuraminidase. The hemagglutinin acts by binding to the sialic acid receptors favoring the entry of the virus into the target cells and the neuraminidase cleaves the receptor cells of sialic acid residues, where the new viral particles are binding. Through this breakdown there will be release of the new particles that through hemagglutinin will attack new cells. Based on these, drugs were developed in an attempt to inhibit the action of neuraminidase, so called neuraminidase inhibitors that interfere in the release of these new viral particles avoiding the spread of infection in the respiratory tract. Among the inhibitors, oseltamivir is the drug of choice for prophylaxis and treatment of influenza A, but reports of resistance to this drug have been described, which has caused concern in health professionals and rulers. The HIS275TIR mutation is most commonly found, where histidine is replaced by a tyrosine, promoting a series of conformational changes that decrease the affinity of the drug for the virus causing resistance. Based on crystallographic data and computational simulation, we calculated the interaction energy of the wild neuraminidase and the presence of the HIS275TIR mutation bonded to oseltamivir using the Functional Density Theory (DFT) and the Molecular Fractionation with Conjugated Caps (MFCC). We obtained 115 interaction residues for the wild neuraminidase (4B7R crystal) and 109 interaction residues for the crystal with the mutant neuraminidase (3CL0). The results were evaluated according to the relevance of the energy values for repulsive energies and attractive energies. The energetic calculations confirmed the reduction of the affinity of the strain containing the HIS275TIR mutation and highlighted the energy importance of the active site of the neuraminidase, showing that the main energy residues are found in it becoming a target for obtaining new drugs due to its conservation. The changes caused by the substitution of the amino acid histidine for a tyrosine led to a series of conformational changes in the neighboring amino acids that provoked electrostatic changes resulting in the resistance to the drug. From this study, it will be possible to know better the molecular interactions of the mutant neuraminidase and subsequently to project new drugs designs to be elaborated and become more efficient in the interaction with the mutant strains of this virus.
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.ufrn.br:123456789/24058 |
| Date | 19 April 2017 |
| Creators | Manso, Dalila Nascimento |
| Contributors | 67196675487, Oliveira, Jonas Ivan Nobre, 01193849497, Caetano, Ewerton Wagner Santos, 71030930325, Fulco, Umberto Laino |
| Publisher | PROGRAMA DE P?S-GRADUA??O EM CI?NCIAS BIOL?GICAS, UFRN, Brasil |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Source | reponame:Repositório Institucional da UFRN, instname:Universidade Federal do Rio Grande do Norte, instacron:UFRN |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0033 seconds